APD

Air Products & Chemicals, Inc. - Q2 2005 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2005, and the six-month period ended on the same date. Air Products & Chemicals, Inc. operates globally in three primary segments: Gases (industrial gases, medical gases, and electronic specialty materials), Chemicals (performance materials and chemical intermediates), and Equipment (liquefied natural gas heat exchangers and other equipment). The company reported strong operational performance driven by volume growth, favorable currency effects, and productivity gains.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 8% in Q2 and 13% YTD. Growth was driven by a 4% increase in underlying volumes (primarily in Gases), favorable currency effects (weaker U.S. dollar), and cost pass-throughs for natural gas/raw materials.
• Profitability: Operating income rose 20% in Q2 and 20% YTD. This was primarily due to volume gains, lower costs from productivity initiatives, and favorable currency impacts. The Chemicals segment saw a 30% operating income increase in Q2 due to price increases and cost recovery.
• Segment Performance:
  • Gases: Sales up 10% (Q2) and 15% (YTD). Strong volumes in North America and Asia base gases, refinery hydrogen, and electronics.
  • Chemicals: Sales up 3% (Q2) and 7% (YTD). Operating income improved significantly in Q2 after Q1 challenges with raw material costs.
  • Equipment: Sales up 4% (Q2) and 12% (YTD), driven by LNG heat exchanger activity.
• Divestitures: The sale of the European methylamines and derivatives (EM&D) business and Mexican polymers business reduced sales by approximately 2% in Q2 and 1% YTD.

Guidance, Outlook, and Risks

• 2005 Outlook: Management expects continued volume gains in the second half of the year, particularly in refinery hydrogen and healthcare. The company anticipates pricing pressure in electronic specialty materials but expects volume growth to offset declines later in the year.
• Capital Allocation:
  • Announced a $500 million share repurchase program on March 17, 2005.
  • Increased the quarterly cash dividend by 10% to $0.32 per share.
  • Capital expenditures for 2005 are forecast at $950 million to $1,000 million, with an additional $75-$100 million for homecare acquisitions.
• Risks and Contingencies:
  • INOX Put Option: A revised put option agreement with INOXAP shareholders allows them to require the company to purchase shares at a minimum of 630 Rupees per share (approx. $74 million total) between 2010-2011.
  • Legal: An appeal regarding a breach of contract suit with Honeywell International is pending; the Delaware Supreme Court ruled on a recalculation of damages in March 2005.
  • Supplier Risk: A long-term sulfuric acid supplier emerged from bankruptcy; the company has provided $59.6 million in loans. Failure of this supplier could materially impact the Chemicals segment.
  • Accounting Changes: The company plans to adopt SFAS No. 123R (share-based payment) on October 1, 2005, which is expected to reduce diluted EPS by approximately $0.12 in 2005.

Investor Verification Checklist

• Verify the impact of the pending Honeywell litigation appeal on potential future liabilities.
• Monitor the financial stability of the sulfuric acid supplier and the recoverability of the $59.6 million loan.
• Assess the execution of the $500 million share repurchase program and its timing relative to market conditions.
• Track the adoption of SFAS No. 123R and its specific impact on reported earnings in the third and fourth quarters.
• Review the progress of homecare acquisitions and their integration into the Gases segment.